Selected research
Market Outlook & Growth Opportunities
Global Opioid Pain Patche Market Outlook and Growth Opportunities 2026
Market perspective
The global Opioid Pain Patche market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Opioid Pain Patche market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Opioid Pain Patche market include Teva Pharmaceutical Industries, Sanofi, Novartis, GlaxoSmithKline, Viatris, Teikoku Seiyaku, Nichiban, Mentholatum and Johnson & Johnson Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Opioid Pain Patche market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Opioid Pain Patche and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Opioid Pain Patche sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Pain Patche market size, projected growth trends, production technologies, key applications, and end-use industries.
Opioid Pain Patche Segment by Company
Teva Pharmaceutical Industries
Sanofi
Novartis
GlaxoSmithKline
Viatris
Teikoku Seiyaku
Nichiban
Mentholatum
Johnson & Johnson Services
Hisamitsu Pharmaceutical
Opioid Pain Patche Segment by Type
Opioid Patches
Non-opioid Patches
Opioid Pain Patche Segment by Application
Retail Pharmacies
Online pharmacies
Hospital Pharmacies
Opioid Pain Patche Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Opioid Pain Patche status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioid Pain Patche market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioid Pain Patche significant trends, drivers, influence factors in global and regions.
6. To analyze Opioid Pain Patche competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Pain Patche market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Pain Patche and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Pain Patche.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioid Pain Patche market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Pain Patche industry.
Chapter 3: Detailed analysis of Opioid Pain Patche manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioid Pain Patche in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioid Pain Patche in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Opioid Patches
- Non-opioid Patches
Applications
- Retail Pharmacies
- Online pharmacies
- Hospital Pharmacies
Companies covered
- Teva Pharmaceutical Industries
- Sanofi
- Novartis
- GlaxoSmithKline
- Viatris
- Teikoku Seiyaku
- Nichiban
- Mentholatum
- Johnson & Johnson Services
- Hisamitsu Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Opioid Pain Patche Sales Value (2021-2032)
- 1.2.2 Global Opioid Pain Patche Sales Volume (2021-2032)
- 1.2.3 Global Opioid Pain Patche Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Opioid Pain Patche Market Dynamics
- 2.1 Opioid Pain Patche Industry Trends
- 2.2 Opioid Pain Patche Industry Drivers
- 2.3 Opioid Pain Patche Industry Opportunities and Challenges
- 2.4 Opioid Pain Patche Industry Restraints
3 Opioid Pain Patche Market by Company
- 3.1 Global Opioid Pain Patche Company Revenue Ranking in 2025
- 3.2 Global Opioid Pain Patche Revenue by Company (2021-2026)
- 3.3 Global Opioid Pain Patche Sales Volume by Company (2021-2026)
- 3.4 Global Opioid Pain Patche Average Price by Company (2021-2026)
- 3.5 Global Opioid Pain Patche Company Ranking (2024-2026)
- 3.6 Global Opioid Pain Patche Company Manufacturing Base and Headquarters
- 3.7 Global Opioid Pain Patche Company Product Type and Application
- 3.8 Global Opioid Pain Patche Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Opioid Pain Patche Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Opioid Pain Patche Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Opioid Pain Patche Market by Type
- 4.1 Opioid Pain Patche Type Introduction
- 4.1.1 Opioid Patches
- 4.1.2 Non-opioid Patches
- 4.2 Global Opioid Pain Patche Sales Volume by Type
- 4.2.1 Global Opioid Pain Patche Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Opioid Pain Patche Sales Volume by Type (2021-2032)
- 4.2.3 Global Opioid Pain Patche Sales Volume Share by Type (2021-2032)
- 4.3 Global Opioid Pain Patche Sales Value by Type
- 4.3.1 Global Opioid Pain Patche Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Opioid Pain Patche Sales Value by Type (2021-2032)
- 4.3.3 Global Opioid Pain Patche Sales Value Share by Type (2021-2032)
5 Opioid Pain Patche Market by Application
- 5.1 Opioid Pain Patche Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Opioid Pain Patche Sales Volume by Application
- 5.2.1 Global Opioid Pain Patche Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Opioid Pain Patche Sales Volume by Application (2021-2032)
- 5.2.3 Global Opioid Pain Patche Sales Volume Share by Application (2021-2032)
- 5.3 Global Opioid Pain Patche Sales Value by Application
- 5.3.1 Global Opioid Pain Patche Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Opioid Pain Patche Sales Value by Application (2021-2032)
- 5.3.3 Global Opioid Pain Patche Sales Value Share by Application (2021-2032)
6 Opioid Pain Patche Regional Sales and Value Analysis
- 6.1 Global Opioid Pain Patche Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Opioid Pain Patche Sales by Region (2021-2032)
- 6.2.1 Global Opioid Pain Patche Sales by Region: 2021-2026
- 6.2.2 Global Opioid Pain Patche Sales by Region (2027-2032)
- 6.3 Global Opioid Pain Patche Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Opioid Pain Patche Sales Value by Region (2021-2032)
- 6.4.1 Global Opioid Pain Patche Sales Value by Region: 2021-2026
- 6.4.2 Global Opioid Pain Patche Sales Value by Region (2027-2032)
- 6.5 Global Opioid Pain Patche Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Opioid Pain Patche Sales Value (2021-2032)
- 6.6.2 North America Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Opioid Pain Patche Sales Value (2021-2032)
- 6.7.2 Europe Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Opioid Pain Patche Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Opioid Pain Patche Sales Value (2021-2032)
- 6.9.2 South America Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Opioid Pain Patche Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
7 Opioid Pain Patche Country-level Sales and Value Analysis
- 7.1 Global Opioid Pain Patche Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Opioid Pain Patche Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Opioid Pain Patche Sales by Country (2021-2032)
- 7.3.1 Global Opioid Pain Patche Sales by Country (2021-2026)
- 7.3.2 Global Opioid Pain Patche Sales by Country (2027-2032)
- 7.4 Global Opioid Pain Patche Sales Value by Country (2021-2032)
- 7.4.1 Global Opioid Pain Patche Sales Value by Country (2021-2026)
- 7.4.2 Global Opioid Pain Patche Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.9.2 France Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.16.2 China Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.19.2 India Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Opioid Pain Patche Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceutical Industries
- 8.1.1 Teva Pharmaceutical Industries Company Information
- 8.1.2 Teva Pharmaceutical Industries Business Overview
- 8.1.3 Teva Pharmaceutical Industries Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Industries Opioid Pain Patche Product Portfolio
- 8.1.5 Teva Pharmaceutical Industries Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Sanofi Opioid Pain Patche Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Novartis Opioid Pain Patche Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 GlaxoSmithKline
- 8.4.1 GlaxoSmithKline Company Information
- 8.4.2 GlaxoSmithKline Business Overview
- 8.4.3 GlaxoSmithKline Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline Opioid Pain Patche Product Portfolio
- 8.4.5 GlaxoSmithKline Recent Developments
- 8.5 Viatris
- 8.5.1 Viatris Company Information
- 8.5.2 Viatris Business Overview
- 8.5.3 Viatris Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Viatris Opioid Pain Patche Product Portfolio
- 8.5.5 Viatris Recent Developments
- 8.6 Teikoku Seiyaku
- 8.6.1 Teikoku Seiyaku Company Information
- 8.6.2 Teikoku Seiyaku Business Overview
- 8.6.3 Teikoku Seiyaku Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Teikoku Seiyaku Opioid Pain Patche Product Portfolio
- 8.6.5 Teikoku Seiyaku Recent Developments
- 8.7 Nichiban
- 8.7.1 Nichiban Company Information
- 8.7.2 Nichiban Business Overview
- 8.7.3 Nichiban Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Nichiban Opioid Pain Patche Product Portfolio
- 8.7.5 Nichiban Recent Developments
- 8.8 Mentholatum
- 8.8.1 Mentholatum Company Information
- 8.8.2 Mentholatum Business Overview
- 8.8.3 Mentholatum Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Mentholatum Opioid Pain Patche Product Portfolio
- 8.8.5 Mentholatum Recent Developments
- 8.9 Johnson & Johnson Services
- 8.9.1 Johnson & Johnson Services Company Information
- 8.9.2 Johnson & Johnson Services Business Overview
- 8.9.3 Johnson & Johnson Services Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Johnson & Johnson Services Opioid Pain Patche Product Portfolio
- 8.9.5 Johnson & Johnson Services Recent Developments
- 8.10 Hisamitsu Pharmaceutical
- 8.10.1 Hisamitsu Pharmaceutical Company Information
- 8.10.2 Hisamitsu Pharmaceutical Business Overview
- 8.10.3 Hisamitsu Pharmaceutical Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Hisamitsu Pharmaceutical Opioid Pain Patche Product Portfolio
- 8.10.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Opioid Pain Patche Value Chain Analysis
- 9.1.1 Opioid Pain Patche Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Opioid Pain Patche Sales Mode & Process
- 9.2 Opioid Pain Patche Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Opioid Pain Patche Distributors
- 9.2.3 Opioid Pain Patche Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst